Defying death: The longevity lab

Gene and stem cell therapies have been touted as the next phase in the longevity movement, with promises to rejuvenate the body at the cellular level and reverse the effects of ageing. But, as the prospect of life extension moves into the mainstream, it presents big questions for ...  Show more

How much do we really know about ageing? For decades, scientists have been trying to understand the biology of the ageing process - what happens to our bodies as we get older? And is it possible to slow that process down or even stop it all together?

In this series o ...

Torsten Reil is the Co-Founder and Co-CEO of Helsing, a new type of defence company providing artificial intelligence to protect our democracies. Torsten has raised over $825M from the likes of Prima Materia, Elad Gil, Accel and General Catalyst. Previously Torsten f ...

European countries have committed to higher defence spending to face down Russian aggression. But preparing for war isn’t cheap – and in many countries, budgets are already stretched. How will European members of Nato hit their defence targets, a hefty 5% of GDP? Will EU states l ...  Show more

Investors are urging the EU to make sweeping reforms to its debt securitisation market, Walmart has staged a major comeback, and Chinese ecommerce giant Alibaba reported its fastest revenue growth in more than a year. Plus, the FT’s John Paul Rathbone explains how Europe could ...

Europe is facing its biggest defence challenge since the second world war. This is compounded by the destabilising impact of US tariffs. So how is it measuring up? Gideon puts this question to Arancha González Laya, dean of the Paris School of International Affairs at Science Po ...  Show more